NEVVI Medicare utilization intelligence

← back

LU, KEVINM.D. NPI 1457701831 Clinician

Internal Medicine · WILLOW GROVE, PA

Specialty Internal Medicine — from billed Medicare claims
Trained STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 10 years since medical school (class of 2016, self-reported to CMS)
Location WILLOW GROVE, PA · NPPES registered location
Active in data Billed Medicare 2021–2024 (4 consecutive years)
Scale 26 codes billed · 80,343 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20222026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-08

Year: 2024 · 2023 · 2022 locked column · 2021 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J3262 Injection, tocilizumab, 1 mg premiumpremium premiumpremium
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J3111 Injection, romosozumab-aqqg, 1 mg premiumpremium premiumpremium
J1602 Injection, golimumab, 1 mg, for intravenous use premiumpremium premiumpremium
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) premiumpremium premiumpremium
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg premiumpremium premiumpremium
J1745 Injection, infliximab, excludes biosimilar, 10 mg premiumpremium premiumpremium
J9312 Injection, rituximab, 10 mg premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J1010 Injection, methylprednisolone acetate, 1 mg premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
20610 Aspiration and/or injection of fluid from large joint premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
20600 Aspiration and/or injection of fluid from small joint premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.